SCHEMBL12837140

SCHEMBL12837140

Bc1cccc(Nc2nccc(-c3cnc(-c4cccnc4)n3C)n2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 16/20 0.58
▸ BCR P11274 14/20 0.58
▸ PRKCA P17252 12/20 0.53
▸ SRC P12931 10/20 0.53
▸ PRKCD Q05655 9/20 0.53
▸ EGFR P00533 4/20 0.53
▸ PRKACA P17612 1/20 0.53
▸ PRKACG P22612 1/20 0.53
▸ PRKACB P22694 1/20 0.53
▸ PDGFRB P09619 5/20 0.49
▸ PDGFRA P16234 5/20 0.49
▸ KDR P35968 1/20 0.48
▸ PRKD3 O94806 2/20 0.47
▸ PRKCG P05129 2/20 0.47
▸ PRKCB P05771 2/20 0.47
▸ PRKCH P24723 2/20 0.47
▸ PRKCI P41743 2/20 0.47
▸ PRKCE Q02156 2/20 0.47
▸ PRKCQ Q04759 2/20 0.47
▸ PRKCZ Q05513 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8246544 0.88 ABL1 (0.58) ABL1BCRPRKCASRCPRKCD
SCHEMBL8255847 0.86 PIK3CG (0.59) ABL1BCRPRKCASRCPRKCD
SCHEMBL11924749 0.84 ABL1 (0.62) ABL1BCRPRKCASRCPRKCD
SCHEMBL8252396 0.83 ABL1 (0.77) ABL1BCRPRKCASRCPRKCD
SCHEMBL8253620 0.82 PRKCA (0.55) ABL1BCRPRKCASRCPRKCD
SCHEMBL11929046 0.80 ABL1 (0.53) ABL1BCRPRKCASRCPRKCD
SCHEMBL8246547 0.78 ABL1 (0.58) ABL1BCRPRKCASRCPRKCD
SCHEMBL7476769 0.74 ABL1 (1.00) ABL1BCRPRKCASRCPRKCD
SCHEMBL6106194 0.72 CDK2 (0.63) ABL1BCRPRKCAPRKCDKDR
SCHEMBL4084867 0.72 ABL1 (0.77) ABL1BCRPRKCASRCPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7897572-B1 Theraputic methods for type I diabetes UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL (US) 2011-03-01 — — US disclosed
Send feedback